ACAT inhibitors: evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents

This publication has 36 references indexed in Scilit:

• Difference between Normal and WHHL Rabbits in Susceptibility to the Adrenal Toxicity of an Acyl-CoA:Cholesterol Acyltransferase Inhibitor, FR145237
  Toxicology and Applied Pharmacology, 1996
• Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Hepatic and Adrenal Toxicity of a Novel Lipid Regulator in Beagle Dogs
  Fundamental and Applied Toxicology, 1995
• The structure of acyl coenzyme A-cholesterol acyltransferase and its potential relevance to atherosclerosis
  Trends in Cardiovascular Medicine, 1994
• RP 73163, a novel systemic ACAT-Inhibitor induces coarse vacuolation and impairs steroid hormone metabolism in guinea pig adrenocortical cells
  Toxicology Letters, 1994
• Subacute Toxicity of a Novel Inhibitor of Acyl-CoA: Cholesterol Acyltransferase in Beagle Dogs
  Fundamental and Applied Toxicology, 1993
• ATP Depletion Is Associated with Cytotoxicity of a Novel Lipid Regulator in Guinea Pig Adrenocortical Cells
  Toxicology and Applied Pharmacology, 1993
• Atherosclerotic risk factors — are there ten, or is there only one?
  Atherosclerosis, 1992
• Clinical Implications of New Drugs for Lowering Plasma Cholesterol Concentrations
  Drugs, 1991
• Metabolism of cholesteryl ester in monolayers of bovine adrenal cortical cells. Effect of an inhibitor of acyl-CoA : cholesterol acyltransferase
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985